Dr. Prodromos Gordon Borboroglu, MD

Dr. Borboroglu practices at Prody Urology in Melbourne, Florida.

Dr. Borboroglu's NPI, 1770543894, was assigned on March 24, 2006. Dr. Borboroglu graduated from Sidney Kimmel Medical College in 1994. Dr. Borboroglu holds Florida license ME99271.

Dr. Borboroglu's primary practice is Prody Urology, at 575 S Wickham Rd, Melbourne, FL 32904 in Brevard County. The practice phone is (321) 308-5060.

Dr. Borboroglu's primary practice is Prody Urology in Melbourne, Florida. Dr. Borboroglu is also affiliated with Holmes Regional Medical Center. Dmand AI also links Dr. Borboroglu to 4 more hospitals, 2 home health agencies and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Borboroglu practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Borboroglu's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Borboroglu is board certified in urology by the American Board of Urology. Dmand AI has Dr. Borboroglu's licenses on file in 4 states: Florida, Virginia, Wisconsin and Maryland.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, prostate inflammation or infection and testicular dysfunction among the conditions Dr. Borboroglu treats.

CMS data shows 2,901 Medicare services from Dr. Borboroglu across 27 procedure codes in 2024, for 583 Medicare patients. Medicare paid $494,688 for them.

CMS counts 583 Medicare patients who saw Dr. Borboroglu in 2024. The largest group is 65 to 74, with 255 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Borboroglu's median patient age at 72, with 19% women.

In 2024, Dr. Borboroglu wrote 3,379 Medicare Part D claims for 890 patients. 91% of them were for generic drugs. CMS names the drug for 3,293 of them, across 27 drugs with 11 or more claims each, at $289,462 in total drug cost. In 2023, CMS named 3,085 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Borboroglu for performance year 2024, reported individually. Dr. Borboroglu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 23 procedures of prostate resection by Dr. Borboroglu, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Borboroglu. The most frequent topics are Prostatic Neoplasms, Biopsy and Prostatectomy. Dr. Borboroglu has published most often in J Urol. Dr. Borboroglu's most frequent co-authors are Christopher Lee Amling, FACS, MD, James Lincoln Roberts, MD and Roger Lu Sur, MD.

CMS Open Payments shows 32 general payments to Dr. Borboroglu from 16 drug and device companies from 2016 to 2025. Debt forgiveness make up the largest share, 76% of the total. Olympus America Inc. paid the most, $1,500.

Dmand AI lists 3 awards for Dr. Borboroglu, most recently ACS Fellow in 2013.

Dr. Borboroglu graduated from Sidney Kimmel Medical College in 1994. Dr. Borboroglu is a member of ACS.

Dr. Borboroglu is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.